AAMU
CYCN icon

Amundi Asset Management US’s Cyclerion Therapeutics CYCN Stock Holding History

Amundi Asset Management US’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed – – 1545
2020
Q4 		$0 Hold
2
– – ﹤0.01% 1498
2020
Q3 		$0 Hold
2
– – ﹤0.01% 1612
2020
Q2 		$0 Hold
2
– – ﹤0.01% 1632
2020
Q1 		$0 Hold
2
– – ﹤0.01% 1613
2019
Q4 		$0 Hold
2
– – ﹤0.01% 1620
2019
Q3 		$0 Sell
2
-25
-93% -$5.4K ﹤0.01% 1647
2019
Q2 		$6K Buy
+27
New +$7.64K ﹤0.01% 1627

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return